Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Joseph Beechem, Hugh Martin

Premium

Joseph Beechem has left his position as head of advanced sequencing and global sequencing chemistry, biochemistry, and biophysics at Life Technologies to join NanoString as senior vice president of research and development.

While at Life Tech, he led the design and development of multiple sequencing technologies for the SOLiD platform, including an emulsion PCR-free sample-prep technology called WildFire that Life Tech plans to launch this year. He holds a BS in chemistry and biology from Northern Kentucky University and a PhD in biophysics from Johns Hopkins University.

Beechem has also served as chief technology officer at Life Tech, chief scientific officer of Invitrogen, and director of biosciences at Molecular Probes.


Hugh Martin has resigned from Pacific Biosciences' board of directors for personal reasons, effective immediately. Martin was previously the firm's president and CEO but resigned at the beginning of the year and was replaced by Michael Hunkapiller (IS 1/10/2012). He had led the company since 2004 and has been battling multiple myeloma, with which he was diagnosed in 2009.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.